Trovagene Inc (NASDAQ:TROV)

8.43
Delayed Data
As of 3:59pm ET
 -0.47 / -5.28%
Today’s Change
2.97
Today|||52-Week Range
9.18
+96.05%
Year-to-Date

Today’s Trading

Previous close8.90
Today’s open8.95
Day’s range8.16 - 9.05
Volume359,725
Average volume (3 months)388,750
Market cap$216.9M
Dividend yield--
Data as of 3:59pm ET, 05/05/2015

Growth & Valuation

Earnings growth (last year)-25.71%
Earnings growth (this year)-28.62%
Earnings growth (next 5 years)--
Revenue growth (last year)+8.07%
P/E ratioNM
Price/Sales290.13
Price/Book20.16

Competitors

 Today’s
change
Today’s
% change
VCYTVeracyte Inc-0.39-4.37%
QTNTQuotient Ltd+0.57+4.12%
TTHITransition Therapeut...-0.01-0.15%
CALACalithera Bioscience...-0.36-3.65%
Data as of 4:00pm ET, 05/05/2015

Financials

Next reporting dateMay 6, 2015
EPS forecast (this quarter)-$0.24
Annual revenue (last year)$280.2K
Annual profit (last year)-$14.3M
Net profit margin-5,112.99%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Antonius P. Schuh
Chief Financial Officer
Stephen L. Zaniboni
Corporate headquarters
San Diego, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers